Brief: Oncolytics Biotech Inc Qtrly Loss Per Share $0.26
Aug 13 (Reuters) - Oncolytics Biotech Inc ONC.TO :
* ONCOLYTICS BIOTECH INC - AT JUNE 30, 2019, CO REPORTED
$12.3
MILLION IN CASH AND CASH EQUIVALENTS
* ONCOLYTICS BIOTECH INC- QTRLY LOSS PER SHARE $0.26
Source text: (ID: https://bit.ly/2N2SxAf)
Further company coverage: ONC.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Oncolytics Biotech
See all newsBrief: Oncolytics Biotech Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Oncolytics Biotech® Announces Voluntary Delisting From The Toronto Stock Exchange
Advisory: Alert on global oncology breakthroughs tagged to multiple pharma firms withdrawn
Brief: Oncolytics Biotech® Appoints Former Ambrx Executive As Chief Business Officer
Brief: Oncolytics Biotech Appoints Former Ambrx Executive As Chief Business Officer